0000318989-18-000018.txt : 20180405
0000318989-18-000018.hdr.sgml : 20180405
20180405122839
ACCESSION NUMBER: 0000318989-18-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180403
FILED AS OF DATE: 20180405
DATE AS OF CHANGE: 20180405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FIL Ltd
CENTRAL INDEX KEY: 0000318989
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 18739905
BUSINESS ADDRESS:
STREET 1: P.O. BOX H.M. 670
CITY: HAMILTON
STATE: D0
ZIP: 00000
BUSINESS PHONE: 6175637100
MAIL ADDRESS:
STREET 1: P.O. BOX H.M. 670
CITY: HAMILTON
STATE: D0
ZIP: 00000
FORMER NAME:
FORMER CONFORMED NAME: FIL LTD
DATE OF NAME CHANGE: 20080213
FORMER NAME:
FORMER CONFORMED NAME: FIDELITY INTERNATIONAL LTD
DATE OF NAME CHANGE: 19920929
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unum Therapeutics Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-04-03
1
0001622229
Unum Therapeutics Inc.
UMRX
0000318989
FIL Ltd
P.O. BOX H.M. 670
HAMILTON
D0
00000
BERMUDA
0
0
0
1
See Remark 1
Common Stock
2018-04-03
4
C
0
1110932
A
1110932
D
Common Stock
2018-04-03
4
C
0
27342
A
1138274
D
Series A Preferred Stock
2018-04-03
4
C
0
1744310
D
Common Stock
1110932
0
D
Series B Preferred Stock
2018-04-03
4
C
0
42931
D
Common Stock
27342
0
D
On April 3, 2018, in connection with the completion of the issuer's initial public offering, each 1.5701314513884 shares of Series A and Series B Preferred Stock converted into 1 share of Common Stock.
Remark 1: Pandanus Partners, L.P. ("Pandanus") owns shares of FIL Limited ("FIL") voting stock. While the percentage of total voting power represented by these shares of FIL voting stock may fluctuate as a result of changes in the total number of shares of FIL voting stock outstanding from time to time, it normally represents more than 25% and less than 48.5% of the total votes which may be cast by all holders of FIL voting stock. Pandanus Associates, Inc. ("PAI") acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including FIL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this form. The address of Pandanus is c/o FIL Limited, 42 Crow Lane, Hamilton, Bermuda, HM19. The address of PAI is 11 Keewaydin Drive, Suite 100, Salem, NH, USA, 03079.
Marc R. Bryant, Duly authorized under Powers of Attorney effective as of September 16, 2015, by and on behalf of FIL Limited and its direct and indirect subsidiaries, Pandanus Partners, L.P. and Pandanus Associates, Inc.
2018-04-04